News Daily News FDA Green-lights Empagliflozin for HF With Reduced Ejection Fraction Michael O'Riordan August 19, 2021
News Daily News Getting More Women in CV Research Will ‘Take a Village’ Yael L. Maxwell August 09, 2021
News Daily News Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists Todd Neale July 09, 2021
News Daily News Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results Todd Neale July 06, 2021
News Daily News Periprocedural MIs Associated With PCI Prognostically Relevant: ESC/EAPCI Michael O'Riordan June 10, 2021
News Daily News Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds L.A. McKeown June 03, 2021
News Daily News Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care Shelley Wood May 27, 2021
News Daily News Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA Michael O'Riordan April 26, 2021
News Daily News Pneumonia in HF Patients Is Common, Lethal, and Preventable L.A. McKeown April 19, 2021
News Daily News Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF Michael O'Riordan April 15, 2021
News Daily News No Gravity, Smaller Hearts: LV Mass Declines in Space and Water Michael O'Riordan March 29, 2021
News Daily News Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF L.A. McKeown March 25, 2021
News Daily News New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF Todd Neale February 16, 2021
News Daily News CABANA Supports Use of AF Ablation in Patients With Heart Failure Todd Neale February 12, 2021
News Daily News Machine Learning ‘Sniffs’ Out Long QT Otherwise Unseen on ECG Yael L. Maxwell February 11, 2021